Tixel i® is an effective, long-term solution to dry eye.
Tixel i® is an FDA-cleared device for the application of localized heat and pressure therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (MGD). Powered by proprietary Thermo-Mechanical Action (TMA®), treatments consist of short pulses of controlled heat applied with gentle pressure through a matrix of self-disinfecting, titanium pyramids. What sets Tixel i apart from other dry eye treatments is that it only takes 2 minutes for both eyes to be treated. It can be administered by ophthalmologists, optometrists and other allied healthcare professionals. The effectiveness of Tixel i has been scientifically documented in multiple clinical publications, including a multi-center study in the USA that included a 6-month follow-up extension.
We’ll hear from 2 optometrists, Dr. April Jasper and Dr. Lauren Bailey about how this technology is a convenient, efficient way to treat both eyes, with long-lasting impact, with no need to take time off work, no anesthesia or discomfort.
